Trial intelligence / Profile preview

Metformin versus exercise in overweight women with polycystic ovary syndrome

2004-004257-26Phase 4Terminated

Sponsor
Organisation name was not entered
Start
Jan 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of metformin in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Organisation name was not entered. Primary endpoints: Change in insulin resistance and Change in quality of life. Started Jan 2005; status: terminated.

02

Drugs

metformin
03

Conditions

polycystic ovary syndrome (PCOS)

Beyond the preview

Go deeper on 2004-004257-26.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-004257-26.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call